Jude R. Samulski
Executive Chairman
Immunology
Pfizer
Poland
Biography
Dr. Samulski is the scientific founder of Bamboo Therapeutics, Inc. and served as the Chief Scientific Officer and Executive Chairman of the company until its acquisition by Pfizer. Dr. Samulski received his PhD in Medical Microbiology and Immunology from the University of Florida. Dr. Samulski’s graduate work (1978-82) demonstrated the first use of AAV as a viral vector and culminated in the first US patent involving non-AAV genes inserted into AAV.
Research Interest
Dr. Samulski has broad interests in the field of Microbiology and Immunology.
